- Home
- NRXS vs PAVM Comparison
NRXS vs PAVM Comparison
Compare NRXS & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- PAVM
- Stock Information
- Founded
- NRXS 2011
- PAVM 2014
- Country
- NRXS United States
- PAVM United States
- Employees
- NRXS N/A
- PAVM N/A
- Industry
- NRXS
- PAVM Medical/Dental Instruments
- Sector
- NRXS
- PAVM Health Care
- Exchange
- NRXS Nasdaq
- PAVM Nasdaq
- Market Cap
- NRXS 13.0M
- PAVM 12.0M
- IPO Year
- NRXS 2023
- PAVM 2016
- Fundamental
- Price
- NRXS $2.38
- PAVM $0.61
- Analyst Decision
- NRXS Strong Buy
- PAVM Strong Buy
- Analyst Count
- NRXS 1
- PAVM 1
- Target Price
- NRXS $7.00
- PAVM $19.00
- AVG Volume (30 Days)
- NRXS 141.2K
- PAVM 158.5K
- Earning Date
- NRXS 08-08-2025
- PAVM 08-11-2025
- Dividend Yield
- NRXS N/A
- PAVM N/A
- EPS Growth
- NRXS N/A
- PAVM N/A
- EPS
- NRXS N/A
- PAVM 0.96
- Revenue
- NRXS $2,934,945.00
- PAVM $1,993,000.00
- Revenue This Year
- NRXS $138,883.78
- PAVM N/A
- Revenue Next Year
- NRXS $118.59
- PAVM $455.63
- P/E Ratio
- NRXS N/A
- PAVM $0.64
- Revenue Growth
- NRXS 27.52
- PAVM N/A
- 52 Week Low
- NRXS $1.33
- PAVM $0.55
- 52 Week High
- NRXS $6.20
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- NRXS 45.38
- PAVM 43.11
- Support Level
- NRXS $2.33
- PAVM $0.59
- Resistance Level
- NRXS $2.65
- PAVM $0.63
- Average True Range (ATR)
- NRXS 0.15
- PAVM 0.04
- MACD
- NRXS -0.02
- PAVM -0.00
- Stochastic Oscillator
- NRXS 29.27
- PAVM 27.06
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.